DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Sign in and take the values quiz to see how this bill lines up with what you've said.
The 340B PATIENTS Act of 2024 amends the 340B drug discount program to clarify that pharmaceutical manufacturers must offer discounted prices to covered entities (hospitals, clinics, health centers) regardless of how or where drugs are dispensed, including through contract pharmacies. The bill prohibits manufacturers from placing conditions on covered entities' use of the program—such as restricting delivery methods or requiring data submissions—unless approved by the Secretary and determined not to discourage program participation. It also establishes civil monetary penalties of up to $2 million per day for manufacturers that knowingly violate these requirements.
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
Sign in to see how your representatives voted on this bill.